($m), 2007-2012e
Figure 4.20: China’s capabilities across the value chain
Figure 4.21: India’s capabilities across the value chain
Figure 4.22: Number of clinical trials in Latin America, 2000-2008
Figure 4.23: Clinical trials in South Korea, 2005-2009e
Figure 5.24: Revenue growth of top public CROs in 2007-2008
Figure 5.25: Capabilities of leading CROs, 2009
Figure 6.26: Regional presence of major CROs
Figure 6.27: Attractiveness of selected countries for clinical trials
Figure 6.28: Global numbers of phase IV trials 2006-2009e
Figure 6.29: Electronic data capture market size ($m), 2006E-2012e
Figure 6.30: Clinical trials using predictive biomarkers, 2005-2009
List of Tables
Table 1.1: Functions commonly performed by CROs
Table 2.2: The global R&D outsourcing market: five major segments
Table 2.3: SWOT analysis: the full service model
Table 2.4: SWOT analysis: the niche model
Table 2.5: Key deals in the CRO sector
Table 4.6: Major CROs operating in Eastern Europe, 2009
Table 4.7: Domestic Chinese CROs
Table 4.8: Major domestic CROs operating in Latin America, 2009
Table 4.9: Selected domestic CROs in South Korea and Turkey
Table 5.10: Revenues ($m) and growth of major CROs, 2007-2008  
 

For More information please contact :

http://www.aarkstore.com/reports/The-CRO-Market-Outlook-Emerging-markets-leading-players-and-future-trends-34933.html

Related Future Technology Articles